ProPhase Labs, Inc.
ProPhase Labs, Inc. (PRPH) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
prph · stock forecast · 2 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 2 Wall Street analysts in the past 3 months
Buy
2 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$140
Consensus
$140
+139900.0% upside
Low
$140
Median: $140 · Last Close: $0.10
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.11 | ↑ 5.00% |
1-day model range: $0.1–$0.11. Peak: $0.11 (+5.00%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PRPH · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2024-02-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-11-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-06-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-03-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-02-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-02-16 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-02-07 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2022-11-11 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on ProPhase Labs, Inc. (PRPH) stock. Of the recent 15 rating actions, 0 were upgrades and 1 were downgrades. 2 analysts currently cover PRPH.
Analyst Recommendation Trends
PRPH analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$121M
↑ 832.0% YoY
Revenue Next Year
$18M
↓ 85.2% YoY
EPS This Year
$1.12
EPS Next Year
$-1.46
↓ 230.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast PRPH EPS of $1.12 for the current fiscal year, based on estimates from 1 analysts. The PRPH revenue forecast is $121M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The PRPH stock forecast is supported by two independent data sources: analyst consensus ratings from 2 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus PRPH price target is $140.00 (+139900.0% upside), with an analyst consensus of Buy.
The PRPH short-term stock prediction for tomorrow is $0.11 (+5.00%).
ProPhase Labs, Inc. trades on NASDAQ under the ticker PRPH. The PRPH stock outlook for 2027 is broadly positive, supported by a Buy consensus among 50% of covering analysts.
Frequently asked questions
PRPH forecast · 8 questionsAccording to 2 Wall Street analysts, the average 12-month PRPH price target is $140.00, with a high forecast of $140.00 and a low of $140.00. The median price target is shown in the chart above when available. This implies +139900.0% potential upside from the current price of $0.10.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.